Synopsis
0
JDMF
0
EU WC
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
Topical
Solubilizers
Coating Systems & Additives
Thickeners and Stabilizers
Film Formers & Plasticizers
Co-Processed Excipients
Controlled & Modified Release
Granulation
Direct Compression
Surfactant & Foaming Agents
Emulsifying Agents
Taste Masking
Fillers, Diluents & Binders
API Stability Enhancers
Digital Content
DATA COMPILATION #PharmaFlow
Market Place
ABOUT THIS PAGE
A Zinc Sulfate Heptahydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zinc Sulfate Heptahydrate, including repackagers and relabelers. The FDA regulates Zinc Sulfate Heptahydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zinc Sulfate Heptahydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Zinc Sulfate Heptahydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Zinc Sulfate Heptahydrate supplier is an individual or a company that provides Zinc Sulfate Heptahydrate active pharmaceutical ingredient (API) or Zinc Sulfate Heptahydrate finished formulations upon request. The Zinc Sulfate Heptahydrate suppliers may include Zinc Sulfate Heptahydrate API manufacturers, exporters, distributors and traders.
click here to find a list of Zinc Sulfate Heptahydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Zinc Sulfate Heptahydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Zinc Sulfate Heptahydrate active pharmaceutical ingredient (API) in detail. Different forms of Zinc Sulfate Heptahydrate DMFs exist exist since differing nations have different regulations, such as Zinc Sulfate Heptahydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Zinc Sulfate Heptahydrate DMF submitted to regulatory agencies in the US is known as a USDMF. Zinc Sulfate Heptahydrate USDMF includes data on Zinc Sulfate Heptahydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Zinc Sulfate Heptahydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Zinc Sulfate Heptahydrate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Zinc Sulfate Heptahydrate Drug Master File in Korea (Zinc Sulfate Heptahydrate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Zinc Sulfate Heptahydrate. The MFDS reviews the Zinc Sulfate Heptahydrate KDMF as part of the drug registration process and uses the information provided in the Zinc Sulfate Heptahydrate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Zinc Sulfate Heptahydrate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Zinc Sulfate Heptahydrate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Zinc Sulfate Heptahydrate suppliers with KDMF on PharmaCompass.
A Zinc Sulfate Heptahydrate CEP of the European Pharmacopoeia monograph is often referred to as a Zinc Sulfate Heptahydrate Certificate of Suitability (COS). The purpose of a Zinc Sulfate Heptahydrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Zinc Sulfate Heptahydrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Zinc Sulfate Heptahydrate to their clients by showing that a Zinc Sulfate Heptahydrate CEP has been issued for it. The manufacturer submits a Zinc Sulfate Heptahydrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Zinc Sulfate Heptahydrate CEP holder for the record. Additionally, the data presented in the Zinc Sulfate Heptahydrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Zinc Sulfate Heptahydrate DMF.
A Zinc Sulfate Heptahydrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Zinc Sulfate Heptahydrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Zinc Sulfate Heptahydrate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zinc Sulfate Heptahydrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Zinc Sulfate Heptahydrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Zinc Sulfate Heptahydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Zinc Sulfate Heptahydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zinc Sulfate Heptahydrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Zinc Sulfate Heptahydrate suppliers with NDC on PharmaCompass.
Zinc Sulfate Heptahydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Zinc Sulfate Heptahydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zinc Sulfate Heptahydrate GMP manufacturer or Zinc Sulfate Heptahydrate GMP API supplier for your needs.
A Zinc Sulfate Heptahydrate CoA (Certificate of Analysis) is a formal document that attests to Zinc Sulfate Heptahydrate's compliance with Zinc Sulfate Heptahydrate specifications and serves as a tool for batch-level quality control.
Zinc Sulfate Heptahydrate CoA mostly includes findings from lab analyses of a specific batch. For each Zinc Sulfate Heptahydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Zinc Sulfate Heptahydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Zinc Sulfate Heptahydrate EP), Zinc Sulfate Heptahydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zinc Sulfate Heptahydrate USP).
LOOKING FOR A SUPPLIER?
